Table of Contents
DUBLIN, Ohio — Cardinal Health announced today it has acquired Mirixa Corp., a leading provider of technology-enabled solutions for the provision of medication therapy management (MTM) services, from the National Community Pharmacists Association (NCPA). The business will integrate into OutcomesMTM, a pioneer in the MTM market, at Cardinal Health.
This expanded portfolio from Cardinal Health will bring payers an enhanced pharmacy services network and will standardize care delivery, documentation and billing for MTM services.
“For many years, OutcomesMTM and Mirixa have shared a common vision to increase healthcare quality and decrease cost through the appropriate use of medication,” said Tom Halterman, vice president of Medication Therapy Management Solutions at Cardinal Health and founder of OutcomesMTM. “We are excited about this opportunity to unite these two companies and continue to advance this shared vision under the Cardinal Health umbrella.”
Merging the technology platforms deployed by Mirixa and OutcomesMTM is an important priority of the transaction. In addition, this combination simplifies the workflow for pharmacy staffs in retail, clinic and long-term care settings, allowing them to more effectively deliver services to patients.
“When the integration is complete, pharmacists will no longer need to sign in to multiple portals to navigate their MTM opportunities,” added Halterman. “A single, standardized platform will enable any health plan to connect their members with over 100,000 US pharmacists.”
Through the platform, clinical services such as comprehensive medication reviews, medication adherence consultations and other important interventions can be deployed.
“The original objective of Mirixa was to empower and enable independent community pharmacists, which is a vision this integration with OutcomesMTM and Cardinal Health seeks to continue,” said B. Douglas Hoey, pharmacist, MBA and CEO of NCPA. “In addition to benefiting pharmacists, who can work more closely with patients and be reimbursed for high-touch care, MTM services also result in increased adherence to medications. That increased adherence saves money for health plans, employers and taxpayers in the form of reduced healthcare costs overall.”
